Research map: Reply: Chemotherapy for Invasive Papillary Carcinoma: Survival Benefit or Patient Selection?

Back to the article

Papers in this map

  1. Chemotherapy improves survival for patients with lymph node-negative invasive papillary breast cancer with tumors ≥2 cm: a SEER population-based study · Yi-Zi Zheng · 2025 · 2 citations · Cited by this paper
  2. Patient-driven second opinions in oncology: a review · 2026 · Related
  3. Proton-Pump Inhibitor use in combination with a CDK4/6 inhibitor: Is formulation the issue? · 2026 · Related
  4. Durable response to sotorasib in KRAS G12C -mutant intrahepatic cholangiocarcinoma: a case report · 2026 · Related
  5. Neoadjuvant intent anti-programmed death-1 immunotherapy for cutaneous squamous cell carcinoma in patients with hematologic malignancy · 2026 · Related
  6. Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial · 2026 · Related
  7. Renal Dysfunction in Patients with CML on Long-Term First-Line TKI Therapy: A Single-Center Analysis · 2026 · Related
  8. SERENA-6 visual patient-reported outcomes & safety: camizestrant for emerging ESR1 m advanced breast cancer during first-line endocrine-basedtherapy · 2026 · Related
  9. The Role of Adjuvant Chemotherapy in Small Bowel Adenocarcinomas · 2026 · Related
  10. Oncofertility in Gastrointestinal (GI) Oncology – A Pan-European study of the patient perspective · 2026 · Related
  11. Targeted Therapies in the Management of Advanced Medullary Thyroid Cancer · 2026 · Related

Source: OpenAlex (CC0)